When XELJANZ (tofacitinib) was administered as part of a clinical trial for this rheumatoid arthritis treatment, 1336

Question:

When XELJANZ (tofacitinib) was administered as part of a clinical trial for this rheumatoid arthritis treatment, 1336 subjects were given 5 mg doses of the drug, and here are the numbers of adverse reactions: 57 had headaches, 21 had hypertension, 60 had upper respiratory tract infections, 51 had nasopharyngitis, and 53 had diarrhea. Does any one of these adverse reactions appear to be much more common than the others?
Find the relative frequencies using only the adverse reactions, not the total number of treated subjects.
Required
Use the given categorical data to construct the relative frequency distribution.
Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  book-img-for-question

Mathematical Interest Theory

ISBN: 9781470465681

3rd Edition

Authors: Leslie Jane, James Daniel, Federer Vaaler

Question Posted: